Zonisamide sodium salt
SIGMA/Z2001 - ≥98% (HPLC), powder
Synonym: 1,2-
CAS Number: 68291-98-5
Empirical Formula (Hill Notation): C8H7N2NaO3S
Molecular Weight: 234.21
MDL Number: MFCD01744844
Linear Formula: C8H7N2NaO3S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C8H7N2O3S.Na/c9-14(11, |
| InChI key | ZVBIRPKGWOVBLG-UHFFFAOYSA |
| originator | Eisai |
| Quality Level | 100 ![]() |
| SMILES string | [Na]NS(=O)(=O)Cc1noc2cccc |
| solubility | H2O: >5 mg/mL |
| Biochem/physiol Actions: | Zonisamide sodium salt is an anti-epileptic and also scavenges nitric oxide (NO). |
| Biochem/physiol Actions: | Zonisamide sodium salt is an anti-epileptic. It is effective in various animal epilepsy models and humans with both partial and generalized epileptic seizures. Zonisamide sodium salt also scavenges nitric oxide (NO). |
| Features and Benefits: | This compound was developed by Eisai . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10, 100 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| UNSPSC | 12352200 |


